Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD)

Lokesh,; Gulati, N; Saini, A; Singh, S; Gupta, G; MacLoughlin, R; Chellappan, DK; Dua, K; Dureja, H

Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD)

Lokesh, Gulati, N Saini, A Singh, S Gupta, G MacLoughlin, R Chellappan, DK Dua, K

Dureja, H

Permalink

Publisher:: Bentham Science Publishers Ltd.
Publication Type:: Journal Article
Citation:: Current Drug Delivery, 2024, 21
Issue Date:: 2024-03-05

Closed Access

	Filename	Description	Size
	COPD_Nanostructures.pdf	Published version	1.24 MB		View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Lokesh,
dc.contributor.author	Gulati, N
dc.contributor.author	Saini, A
dc.contributor.author	Singh, S
dc.contributor.author	Gupta, G
dc.contributor.author	MacLoughlin, R
dc.contributor.author	Chellappan, DK
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.contributor.author	Dureja, H
dc.date.accessioned	2024-03-10T03:12:07Z
dc.date.available	2024-03-10T03:12:07Z
dc.date.issued	2024-03-05
dc.identifier.citation	Current Drug Delivery, 2024, 21
dc.identifier.issn	1567-2018
dc.identifier.uri	http://hdl.handle.net/10453/176413
dc.description.abstract	<jats:sec> <jats:title>Abstract:</jats:title> <jats:p>Chronic Obstructive Pulmonary Disease (COPD), a chronic lung disease that causes breathing difficulties and obstructs airflow from the lungs, has a significant global health burden and affects millions of people worldwide. The use of pharmaceuticals in COPD treatment is aimed to alleviate symptoms, improve lung function, prevent exacerbations, and enhance the overall quality of life for patients. Nanotechnology holds great promise to alleviate the burden of COPD. The main goal of this review is to present the full spectrum of therapeutics based on nanostructures for the treatment and management of COPD, including nanoparticles, polymeric nanoparticles, polymeric micelles, solid-lipid nanoparticles, liposomes, exosomes, nanoemulsions, nanosuspensions, and niosomes. Nanotechnology is just one of the many areas of research that may contribute to the development of more effective and personalized treatment modalities for COPD patients in the future. Future studies may be focused on enhancing the therapeutic effectiveness of nanocarriers by conducting extensive mechanistic investigations to translate current scientific knowledge for the effective management of COPD with little or no adverse effects.</jats:p> </jats:sec>
dc.language	en
dc.publisher	Bentham Science Publishers Ltd.
dc.relation.ispartof	Current Drug Delivery
dc.relation.isbasedon	10.2174/0115672018289883240226113353
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1115 Pharmacology and Pharmaceutical Sciences
dc.subject.classification	Pharmacology & Pharmacy
dc.subject.classification	3214 Pharmacology and pharmaceutical sciences
dc.title	Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD)
dc.type	Journal Article
utslib.citation.volume	21
utslib.for	1115 Pharmacology and Pharmaceutical Sciences
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
utslib.copyright.status	closed_access	*
dc.date.updated	2024-03-10T03:12:05Z
pubs.publication-status	Published
pubs.volume	21

Abstract:

Abstract: Chronic Obstructive Pulmonary Disease (COPD), a chronic lung disease that causes breathing difficulties and obstructs airflow from the lungs, has a significant global health burden and affects millions of people worldwide. The use of pharmaceuticals in COPD treatment is aimed to alleviate symptoms, improve lung function, prevent exacerbations, and enhance the overall quality of life for patients. Nanotechnology holds great promise to alleviate the burden of COPD. The main goal of this review is to present the full spectrum of therapeutics based on nanostructures for the treatment and management of COPD, including nanoparticles, polymeric nanoparticles, polymeric micelles, solid-lipid nanoparticles, liposomes, exosomes, nanoemulsions, nanosuspensions, and niosomes. Nanotechnology is just one of the many areas of research that may contribute to the development of more effective and personalized treatment modalities for COPD patients in the future. Future studies may be focused on enhancing the therapeutic effectiveness of nanocarriers by conducting extensive mechanistic investigations to translate current scientific knowledge for the effective management of COPD with little or no adverse effects.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/176413